在患有异常HOX/MEIS1表达异常的儿科急性髓性白血病的治疗向
Kristian L Juul-Dam1, Neerav N Shukla2, Todd M Cooper3
1Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
European journal of medical genetics
|January 4, 2024
概括
针对性治疗,如脑膜抑制剂,对具有特定基因变异的儿童急性髓性白血病 (AML) 是有前途的. 这些药物破坏关键的蛋白质复合体,导致白血病细胞死亡,为难以治疗的病例提供了新的希望.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 儿童急性髓性白血病 (AML) 在约三分之一的患者中仍然是致命的,原因是化学抵抗,复发和治疗毒性.
- 特定的遗传亚型,包括具有HOXA/HOXB和MEIS1上调的亚型 (在30%的儿科AML中发现),存在治疗挑战.
- 异常的HOXA/MEIS1表达与KMT2A-r,NUP98-r和NPM1c基因型有关,表明分子脆弱性.
结论:
- 梅因抑制剂代表了对特定儿童AML基因型的有希望的向治疗,其特点是HOXA/MEIS1上调.
- 临床试验,例如由PedAL/EUPAL协调的临床试验,对于评估儿科患者的脑膜抑制剂至关重要.
- 结合治疗涉及脑膜抑制剂可能会增强抗白血病效果,并改善儿童AML治疗的安全性.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


